[Role of radiation therapy in the management of pancreatic cancer].

Date publication

août 2018

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine

Tous les auteurs :
Huguet F, Rivin Del Campo E, Antoni D, Vendrely V, Hammel P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30100126

Résumé

At diagnosis, about 15% of patients with pancreatic cancer present with a resectable tumour, 50% have a metastatic tumour, and 25% a locally advanced tumor (non-metastatic but unresectable due to vascular invasion) or borderline resectable. Despite the technical progress made in the field of radiation therapy and the improvement of the efficacy of chemotherapy, the prognosis of these patients remains very poor. Recently, the role of radiation therapy in the management of pancreatic cancer has been much debated. This review aims to evaluate the role of radiation therapy for these patients.

Mots clés

Adénocarcinome du pancréas, Borderline, Chemoradiotherapy, Chimioradiothérapie, Folfirinox, Gemcitabine, Localement avancé, Locally advanced, Pancreatic adenocarcinoma, Radiation therapy, Radiothérapie

Référence

Cancer Radiother. 2018 Aug 9;: